182 related articles for article (PubMed ID: 38181121)
1. Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study.
Fei X; Du X; Wang J; Liu J; Gong Y; Zhao Z; Cao Z; Fu Q; Zhu Y; Dong L; Dong B; Pan J; Sun W; Xie S; Xue W
Int J Surg; 2024 Mar; 110(3):1450-1462. PubMed ID: 38181121
[TBL] [Abstract][Full Text] [Related]
2. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; Yang BX; He DC; Zhao XJ
Asian J Androl; 2006 Jan; 8(1):45-51. PubMed ID: 16372118
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer biomarker discovery using high performance mass spectral serum profiling.
Oh JH; Lotan Y; Gurnani P; Rosenblatt KP; Gao J
Comput Methods Programs Biomed; 2009 Oct; 96(1):33-41. PubMed ID: 19423179
[TBL] [Abstract][Full Text] [Related]
4. The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.
Nakayama K; Inoue T; Sekiya S; Terada N; Miyazaki Y; Goto T; Kajihara S; Kawabata S; Iwamoto S; Ikawa K; Oosaga J; Tsuji H; Tanaka K; Ogawa O
PLoS One; 2014; 9(9):e107234. PubMed ID: 25233230
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.
Adam BL; Qu Y; Davis JW; Ward MD; Clements MA; Cazares LH; Semmes OJ; Schellhammer PF; Yasui Y; Feng Z; Wright GL
Cancer Res; 2002 Jul; 62(13):3609-14. PubMed ID: 12097261
[TBL] [Abstract][Full Text] [Related]
7. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.
Qu Y; Adam BL; Yasui Y; Ward MD; Cazares LH; Schellhammer PF; Feng Z; Semmes OJ; Wright GL
Clin Chem; 2002 Oct; 48(10):1835-43. PubMed ID: 12324514
[TBL] [Abstract][Full Text] [Related]
8. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834
[TBL] [Abstract][Full Text] [Related]
9. Data-Driven Two-Stage Framework for Identification and Characterization of Different Antibiotic-Resistant Escherichia coli Isolates Based on Mass Spectrometry Data.
Chung CR; Wang HY; Yao CH; Wu LC; Lu JJ; Horng JT; Lee TY
Microbiol Spectr; 2023 Jun; 11(3):e0347922. PubMed ID: 37042778
[TBL] [Abstract][Full Text] [Related]
10. A metabolomic protocol for plant systematics by matrix-assisted laser-desorption/ionization time-of flight mass spectrometry.
Ernst M; Silva DB; Silva R; Monge M; Semir J; Vêncio RZ; Lopes NP
Anal Chim Acta; 2015 Feb; 859():46-58. PubMed ID: 25622605
[TBL] [Abstract][Full Text] [Related]
11. Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms.
Candela A; Guerrero-López A; Mateos M; Gómez-Asenjo A; Arroyo MJ; Hernandez-García M; Del Campo R; Cercenado E; Cuénod A; Méndez G; Mancera L; Caballero JD; Martínez-García L; Gijón D; Morosini MI; Ruiz-Garbajosa P; Egli A; Cantón R; Muñoz P; Rodríguez-Temporal D; Rodríguez-Sánchez B
J Clin Microbiol; 2023 Apr; 61(4):e0104922. PubMed ID: 37014210
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer diagnosis and characterization with mass spectrometry imaging.
Kurreck A; Vandergrift LA; Fuss TL; Habbel P; Agar NYR; Cheng LL
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):297-305. PubMed ID: 29209003
[TBL] [Abstract][Full Text] [Related]
13. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
Skytt A; Thysell E; Stattin P; Stenman UH; Antti H; Wikström P
Int J Cancer; 2007 Aug; 121(3):615-20. PubMed ID: 17410539
[TBL] [Abstract][Full Text] [Related]
14. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
[TBL] [Abstract][Full Text] [Related]
15. Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer.
Grizzle WE; Adam BL; Bigbee WL; Conrads TP; Carroll C; Feng Z; Izbicka E; Jendoubi M; Johnsey D; Kagan J; Leach RJ; McCarthy DB; Semmes OJ; Srivastava S; Srivastava S; Thompson IM; Thornquist MD; Verma M; Zhang Z; Zou Z
Dis Markers; 2003-2004; 19(4-5):185-95. PubMed ID: 15258333
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Gao H; Zheng Z; Yue Z; Liu F; Zhou L; Zhao X
Int J Mol Med; 2012 Nov; 30(5):1061-8. PubMed ID: 22941199
[TBL] [Abstract][Full Text] [Related]
17. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for differential identification of adult Schistosoma worms.
Ebersbach JC; Sato MO; de Araújo MP; Sato M; Becker SL; Sy I
Parasit Vectors; 2023 Jan; 16(1):20. PubMed ID: 36658630
[TBL] [Abstract][Full Text] [Related]
18. A PSA-guided approach for a better diagnosis of prostatic adenocarcinoma based on MALDI profiling and peptide identification.
Fania C; Sogno I; Vasso M; Torretta E; Leone R; Bruno A; Consonni P; Albini A; Gelfi C
Clin Chim Acta; 2015 Jan; 439():42-9. PubMed ID: 25312866
[TBL] [Abstract][Full Text] [Related]
19. Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression.
Huang TL; Cho YT; Su H; Shiea J
Clin Chim Acta; 2013 Sep; 424():175-81. PubMed ID: 23778025
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a clinic machine-learning nomogram for the prediction of risk stratifications of prostate cancer based on functional subsets of peripheral lymphocyte.
Yang C; Liu Z; Fang Y; Cao X; Xu G; Wang Z; Hu Z; Wang S; Wu X
J Transl Med; 2023 Jul; 21(1):465. PubMed ID: 37438820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
